Markel Corporation
NYSE:MKLInsurance - Property & Casualty
-$18.15 today
- Market cap
- $23.73B
- Beta
- 0.67
- P/E (TTM)
- 11.7
- EPS (TTM)
- $157.85
Volume 0.04M
Average 0.07M
MKL EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Markel CorporationNYSE: MKL
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA declines year over year
Q3 FY2026 EBITDA of $383.23M fell 64.3% year over year, behind the -16.8% change in trailing-twelve-month EBITDA. Sequentially, it fell 76.3% from the prior quarter. Over 3 fiscal years it compounded at +110.2% a year.
Context
- EBITDA amounted to 19.8% of revenue in FY2025, down 5.2 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 2 analysts of $2.03B (-38.1%) for the fiscal year ending Dec 2026, a slowdown from the -21.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $383.23M-76.3% QoQ
- Last fiscal yearDec 2025
- $3.29B-21.5% YoY
- LTMSep 2026
- $2.59B-16.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -64.3% | -41.2% | +23.1 pp |
| 1 year | -21.5% | -38.1% | -16.7 pp |
| 3-year CAGR | +110.2% | -14.0% | -124.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 3.29B USD
- Year-over-year change
- -21.5%
- 4-year CAGR
- -2.6%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.29B | -21.5% |
| FY2024 | 2024-12-31 | 4.18B | +32.5% |
| FY2023 | 2023-12-31 | 3.16B | +792.4% |
| FY2022 | 2022-12-31 | 353.94M | -90.3% |
| FY2021 | 2021-12-31 | 3.65B | — |
EBITDA vs competitors
How MKL compares with its peers on the latest reported figures
- MKL's LTM Sep 2026 EBITDA of $2.59B is the 5th highest of the 11 companies compared; the peer median is $1.96B.
- Its year-over-year change of -16.8% is the 9th highest of 11, against a peer median of +6.7%.
- EBITDA amounts to 15.1% of revenue for MKL, versus a peer median of 18.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.71B | -13.0% | +24.3% | 18.9% | |
| LTM Sep 2026 | $11.52B | +37.6% | +25.2% | 23.5% | |
| LTM Jun 2026 | $5.6B | +24.3% | +45.9% | 29.2% | |
| LTM Sep 2026 | $3.55B | -27.7% | +22.9% | 12.2% | |
| LTM Sep 2026 | $2.59B | -16.8% | +110.2% | 15.1% | |
| LTM Sep 2026 | $2.42B | -3.7% | +7.6% | 13.5% | |
| LTM Sep 2026 | $1.5B | +2.3% | +23.2% | 9.9% | |
| LTM Jun 2026 | $1.38B | +21.5% | -1.8% | 16.9% | |
| LTM Sep 2026 | $999.38M | -21.6% | +53.3% | 18.7% | |
| LTM Sep 2026 | $676.43M | +11.2% | +47.6% | 34.6% | |
| LTM Sep 2026 | $520.91M | +13.8% | -10.4% | 26.8% | |
| Peer median (excluding MKL) | $1.96B | +6.7% | +23.7% | 18.8% | |
Competitors are the stored peer set for MKL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.92B | 11.81B | 15.71B | 16.75B | 16.59B |
| Cost of Revenue | 7.03B | 8.41B | 7.63B | 7.48B | 5.08B |
| Gross Profit | 5.89B | 3.41B | 8.08B | 9.27B | 11.51B |
| Gross Margin | 45.6% | 28.8% | 51.4% | 55.4% | 69.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 2.76B | 3.56B | 5.43B | 5.64B | 8.78B |
| Depreciation & Amortization | 336.39M | 309.45M | 319.73M | 342.36M | 347.92M |
| EBITDA | 3.65B | 353.94M | 3.16B | 4.18B | 3.29B |
| EBITDA Margin | 28.3% | 3.0% | 20.1% | 25.0% | 19.8% |
| Operating Income | 3.13B | (151.57M) | 2.65B | 3.64B | 2.73B |
| Operating Margin | 24.2% | -1.3% | 16.9% | 21.7% | 16.5% |
| Interest Income | 384.42M | 464.01M | 751.75M | 938.47M | 988.81M |
| Interest Expense | 183.58M | 196.06M | 185.08M | 204.3M | 205.91M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 3.13B | (151.57M) | 2.65B | 3.64B | 2.73B |
| Pre-Tax Margin | 24.2% | -1.3% | 16.9% | 21.7% | 16.5% |
| Income Tax Expense | 683.96M | (48.21M) | 552.62M | 790.29M | 580.3M |
| Net Income | 2.42B | (216.28M) | 2B | 2.75B | 2.11B |
| Net Margin | 18.8% | -1.8% | 12.7% | 16.4% | 12.7% |
| EPS (Basic) | 176.92 | (23.72) | 147.32 | 199.69 | 169.74 |
| EPS (Diluted) | 176.51 | (23.72) | 146.98 | 199.32 | 169.22 |
| Weighted Avg Shares | 13.77M | 13.58M | 13.35M | 13.02M | 12.7M |
| Weighted Avg Shares (Diluted) | 13.8M | 13.58M | 13.38M | 13.04M | 12.73M |
Markel Corporation
NYSE:MKL
Intrinsic Alpha fair value
Locked
Current Price
$1,940.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.